Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...

In Tuesday's issue of The Lancet Diabetes & Endocrinology, dozens of international medical experts and people with lived ...

Some people are microdosing certain weight loss drugs in an attempt to reap some of the drugs' benefits with fewer of their side effects. But doctors specializing in weight loss say that ...

Learn the crucial differences between Original Medicare and Medicare Advantage appeals, and discover expert strategies for ...

The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.

Two startups team up to help brands target TV viewers based on what and where they buy. And TikTok remains in will-they-won’t ...

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...